Literature DB >> 9722553

The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E.

J Belkner1, H Stender, H Kühn.   

Abstract

The oxidation of low density lipoprotein (LDL) by mammalian 15-lipoxygenases (15-LOX) was implicated in early atherogenesis. We investigated the molecular mechanism of 15-LOX/LDL interaction and found that during short term incubations, LDL cholesterol esters are oxygenated preferentially by the enzyme. Even when the LDL particle was loaded with free linoleic acid, cholesteryl linoleate constituted the major LOX substrate. In contrast, only small amounts of free oxygenated fatty acid isomers were detected, and re-esterification of oxidized fatty acids into the LDL ester lipid fraction was ruled out. When LDL was depleted from alpha-tocopherol, specific oxygenation of the cholesterol esters was not prevented, and the product pattern was not altered. Similar results were obtained at low (LDL/LOX ratio of 1:1) and high LOX loading (LDL/LOX ratio of 1:10) of the LDL particle. During long term incubations (up to 24 h), a less specific product pattern was observed. However, when the hydroperoxy lipids formed by the 15-LOX were immediately reduced by the phospholipid hydroperoxide glutathione peroxidase, when the reaction was carried out with vitamin E-depleted LDL, or when the assay sample was diluted, the specific pattern of oxygenation products was retained over a long period of time. These data suggest that mammalian 15-LOX preferentially oxidize LDL cholesterol esters, forming a specific pattern of oxygenation products. During long term incubations, free radical-mediated secondary reactions, which lead to a more unspecific product pattern, may become increasingly important. These secondary reactions appear to be suppressed when the hydroperoxy lipids formed are immediately reduced, when alpha-tocopherol-depleted LDL was used, or when the incubation sample was diluted. It may be concluded that 15-LOX-initiated LDL oxidation constitutes a dual-type oxygenase reaction with an initial enzymatic and a subsequent nonenzymatic phase. The biological relevance of this dual-type reaction for atherogenesis will be discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722553     DOI: 10.1074/jbc.273.36.23225

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Cholesteryl ester acyl oxidation and remodeling in murine macrophages: formation of oxidized phosphatidylcholine.

Authors:  Patrick M Hutchins; Robert C Murphy
Journal:  J Lipid Res       Date:  2012-06-04       Impact factor: 5.922

2.  Electrospray MS/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions.

Authors:  Patrick M Hutchins; Ernest E Moore; Robert C Murphy
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

3.  A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma.

Authors:  Ayelet Gonen; Soo-Ho Choi; Phuong Miu; Colin Agatisa-Boyle; Daniel Acks; Angela M Taylor; Coleen A McNamara; Sotirios Tsimikas; Joseph L Witztum; Yury I Miller
Journal:  J Lipid Res       Date:  2018-12-18       Impact factor: 5.922

4.  Evolutionary alteration of ALOX15 specificity optimizes the biosynthesis of antiinflammatory and proresolving lipoxins.

Authors:  Susan Adel; Felix Karst; Àngels González-Lafont; Mária Pekárová; Patricia Saura; Laura Masgrau; José M Lluch; Sabine Stehling; Thomas Horn; Hartmut Kuhn; Dagmar Heydeck
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-13       Impact factor: 11.205

5.  Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.

Authors:  T Cyrus; J L Witztum; D J Rader; R Tangirala; S Fazio; M F Linton; C D Funk
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

6.  Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

Authors:  Michelle Armstrong; Christopher van Hoorebeke; Thomas Horn; Joshua Deschamps; J Cody Freedman; Chakrapani Kalyanaraman; Matthew P Jacobson; Theodore Holman
Journal:  Bioorg Med Chem       Date:  2016-08-31       Impact factor: 3.641

7.  Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.

Authors:  Peter B Anning; Barbara Coles; Alexandra Bermudez-Fajardo; Patricia E M Martin; Bruce S Levison; Stanley L Hazen; Colin D Funk; Hartmut Kühn; Valerie B O'Donnell
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 8.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

Review 9.  Mammalian lipoxygenases and their biological relevance.

Authors:  Hartmut Kuhn; Swathi Banthiya; Klaus van Leyen
Journal:  Biochim Biophys Acta       Date:  2014-10-12

Review 10.  Oxidized cholesteryl esters and inflammation.

Authors:  Soo-Ho Choi; Dmitri Sviridov; Yury I Miller
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-06-29       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.